🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a double blind placebo control trial of fecal microbial transplanta...
Status
Terminated
Location
Seattle Children's Hospital
Start Date
2015-01
Trial ID
NCT02272868
Treatments Being Tested
This study will compare two common approaches to pain control after lumbar ...
Status
Enrolling By Invitation
Location
Rothman Orthopaedic Institute
Start Date
2024-07-08
Trial ID
NCT07743606
Treatments Being Tested
Basal-bolus insulin therapy is recommended for patients with poorly control...
Status
Completed
Location
Grady Health System
Start Date
2019-01-15
Trial ID
NCT03737240
Treatments Being Tested
This study is designed as a prospective, randomized, open-label, phase II c...
Status
Recruiting
Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH), Beijing, 100730
Start Date
2025-06-01
Trial ID
NCT07679399
Treatments Being Tested
The purpose of this study was to evaluate the efficacy, safety, and tolerab...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-21
Trial ID
NCT04732117
Treatments Being Tested
The Severe Acute Respiratory Syndrome COronaVirus 2 (SARS-CoV2) is a new an...
Status
Completed
Location
Hospital de Urgência e Emergência de Rio Branco
Start Date
2020-03-28
Trial ID
NCT04321278
Treatments Being Tested
The goal of this clinical trial is to learn whether new adjuvant radiothera...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-01
Trial ID
NCT07200141
This is a prospective, randomized study to compare the efficacy of TP (Taxa...
Status
Completed
Location
Xijing Hospital
Start Date
2021-01-01
Trial ID
NCT07115095
Treatments Being Tested
Primary Objective: To evaluate the effect of alirocumab (SAR236553/REGN727...
Status
Completed
Location
Investigational Site Number 840616
Start Date
2011-01
Trial ID
NCT01288469
Treatments Being Tested
IMO 8400 is a second-generation oligonucleotide antagonist of endosomal Tol...
Status
Completed
Location
Centre for Human Drug Research
Start Date
2013-05
Trial ID
NCT01899729
Treatments Being Tested